AcquisitionOther
Mirum Pharmaceuticals, Inc. acquired Travere
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Mirum Pharmaceuticals, Inc. -> Travere · $210 million
Mirums late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults.
Open source record (SEC) ↗